AI-generated summary
The authors randomly assigned 112 stroke patients with depression and insomnia to escitalopram alone or escitalopram plus bright light therapy for 6 weeks. The combined group showed greater improvement in sleep quality remission and depression scores, with few differences in side effects. The authors conclude the combination is effective and well tolerated, though 106 patients completed the study.
- Participants
- 112
- Who or what was studied
- Ischemic stroke patients with poststroke depression and insomnia symptoms
- Limits stated in the abstract
- The abstract does not describe the light wavelength, intensity, or blinding, and the conclusion of effectiveness rests on a single trial with some dropouts.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Depression, Insomnia, Bright light therapy, Stroke. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.